Advanced Search

 

Study ID Status Title Patient Level Data
205194 Adapt and Perform: the Impact of Increased Dietary Protein on the Metabolic Adaptation to Endurance Running and Subsequent Endurance Performance
205194 Completed Adapt and Perform: the Impact of Increased Dietary Protein on the Metabolic Adaptation to Endurance Running and Subsequent Endurance Performance
205194 Completed Adapt and Perform: the Impact of Increased Dietary Protein on the Metabolic Adaptation to Endurance Running and Subsequent Endurance Performance
205201 Completed Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205212 Completed Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205220 Completed A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women aged 18 to 40 Years
205232 A Phase 2b, Controlled, Observer-Blind, Multi-Center Study Assessing the Effectiveness, Immunogenicity and Safety of the 3rd Dose of Novartis Meningococcal ABCWY Vaccine Administered to Healthy Adolescents in the U.S.
205249 Completed A Phase 3, Open Label, Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered concomitantly with Routine Vaccines to Healthy Infants in Taiwan.
205636 Completed A Randomized, Parallel-Group, Placebo-Controlled Study to Evaluate the Local Nasal Tolerability and Safety of 1146A in Healthy Adult Subjects
205643 Completed PGx7654: Pharmacogenetic investigation of the association of the beta2-adrenergic receptor (ADRB2) Thr164Ile variant with risk of hospitalization due to asthma exacerbations
205654 Not yet recruiting MALARONE Pediatric Combination Tablets Special Drug Use Investigation
205697 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205710 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205787 Completed Assessment of Patients Treated with Albiglutide - Phase 1
205795 Completed Sun Protection Factor Determination (In vivo determination of the sun protection factor ISO 24444:2010(E))
205808 Completed A double-blind, randomized, placebo controlled, dose escalating crossover study to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic parameters of single doses of GSK2330672 in Japanese healthy male volunteers
205865 Completed Sun Protection Factor Determination: In vivo Determination of the Sun Protection Factor (SPF): ISO 24444:2010(E)
206 Completed Steady-state bioequivalence evaluation of bupropion sustained-release and bupropion immediate-release tablets in healthy male volunteers
206350 Completed Description of QoL data (SF-36 and FACIT) from the BLISS long-term extension study
206707 Completed Indirect treatment comparison of ropinirole and pramipexole for management of symptoms in patients with advanced Parkinson’s disease
206822 Completed PGx7659: Exploratory Pharmacogenetic Investigation of Efficacy Response to Relvar/Breo in Asthma studies 106827, 106829, 106837, 113091 and 116863
206823 Completed PGx7660: Exploratory Pharmacogenetic Investigation of Efficacy Response to Relvar/Breo in Phase III COPD studies 112206, 112207, 113108, and 200820
207 Completed A bioequivalence study of 50, 100, and 150 mg bupropion sustained-release tablets in healthy male volunteers
207266/084 Completed A Study to Assess the Effect of Repeat Dose NCE on the Steady-State Pharmacokinetics and Pharmacodynamics of Digoxin in Healthy Subjects
207499/039 Completed A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of Cilomilast (15mg Twice Daily) in Patients with Chronic Obstructive Pulmonary Disease (COPD).

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.